Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001080486 | SCV000552354 | benign | Tuberous sclerosis 1 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000034612 | SCV001146271 | benign | not provided | 2018-10-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001017939 | SCV001179108 | benign | Hereditary cancer-predisposing syndrome | 2021-03-18 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV001080486 | SCV002040142 | benign | Tuberous sclerosis 1 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV001017939 | SCV002531493 | uncertain significance | Hereditary cancer-predisposing syndrome | 2021-08-09 | criteria provided, single submitter | curation | |
Myriad Genetics, |
RCV001080486 | SCV005404693 | likely benign | Tuberous sclerosis 1 | 2024-08-27 | criteria provided, single submitter | clinical testing | This variant is considered likely benign. This variant has been observed at a population frequency that is significantly greater than expected given the associated disease prevalence and penetrance. |
Biesecker Lab/Clinical Genomics Section, |
RCV000034612 | SCV000043520 | variant of unknown significance | not provided | 2012-07-13 | no assertion criteria provided | research | Converted during submission to Uncertain significance. |